A Trial of Lopinavir-Ritonavir in Covid-19

N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.

Authors

Salvatore Corrao¹, Giuseppe Natoli², Bruno Cacopardo³

Affiliations

¹ University of Palermo School of Medicine, Palermo, Italy [email protected].
² ARNAS Civico Di Cristina Benfratelli, Palermo, Italy.
³ University of Catania School of Medicine, Catania, Italy.

PMID: 32369284
DOI: 10.1056/NEJMc2008043

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Humans
Lopinavir
Pandemics
Pneumonia, Viral*
Ritonavir*
SARS-CoV-2

Substances

Lopinavir
Ritonavir